[1] Vijayasaradhi M, Prasad VB.  Moyamoya disease presenting as bilateral acute subdural hematomas without deficits[J]. Asian J Neurosurg, 2017, 12(2): 228-231.   doi: 10.4103/1793-5482.149997
[2] Kang CG, Chun MH, Kang JA, et al.  Neurocognitive Dysfunction According to Hypoperfusion Territory in Patients with Moyamoya Disease[J]. Ann Rehabil Med, 2017, 41(1): 1-8.   doi: 10.5535/arm.2017.41.1.1
[3] Fujimura M, Bang OY, Kim JS.  Moyamoya Disease[J]. Front Neurol Neurosci, 2016, 40: 204-220.   doi: 10.1159/000448314
[4] Magsi S, Khoja A, Rameez MAM, et al.  Bilateral Moyamoya Disease in a 2-Year-Old Pakistani Male Treated with Bilateral Encephaloduroarteriosynangiosis: A Positive Outcome[J]. Case Rep Neurol Med, 2016, 2016: 1467582-.   doi: 10.1155/2016/1467582
[5] Güçlü H, Gurlu VP, Ozal SA, et al.  A Moyamoya Patient with Bilateral Consecutive Branch Retinal Vein Occlusion[J]. Neuro-Ophthalmol, 2016, 40(2): 93-96.   doi: 10.3109/01658107.2016.1148174
[6] Tian B, Jiang Y, Kang Q, et al.  Comparative study of 4D CTA and DSA for vascular assessment in moyamoya disease[J]. Clin Imaging, 2018, 48: 74-78.   doi: 10.1016/j.clinimag.2017.10.005
[7] Volkan-Salanci B, Lay Ergün E, Genc Sel Ç, et al.  The role of brain perfusion SPECT in Moyamoya disease[J]. Rev Esp Med Nucl Imagen Mol, 2012, 31(4): 216-218.   doi: 10.1016/j.remn.2012.02.006
[8] Lee SU, Chung YS, Oh CW, et al.  Cerebrovascular Events During Pregnancy and Puerperium Resulting from Preexisting Moyamoya Disease: Determining the Risk of Ischemic Events Based on Hemodynamic Status Assessment Using Brain Perfusion Single-Photon Emission Computed Tomography[J]. World Neurosurg, 2016, 90: 66-75.   doi: 10.1016/j.wneu.2016.02.062
[9]

Fushimi Y, Okada T, Takagi Y, et al. Voxel Based Analysis of Surgical Revascularization for Moyamoya Disease: Pre-and Postoperative SPECT Studies[J/OL]. PLoS One, 2016, 11(2): e0148925. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0148925. DOI: 10.1371/journal.pone.0148925.
[10] Drouet C, Morel O, Thines L, et al.  Brain Perfusion Before and After Surgical Treatment of Moyamoya Disease[J]. Clin Nucl Med, 2017, 42(5): e269-e272.   doi: 10.1097/RLU.0000000000001606
[11] So Y, Lee HY, Kim SK, et al.  Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery[J]. Stroke, 2005, 36(7): 1485-1489.   doi: 10.1161/01.STR.0000170709.95185.b1
[12] Roder C, Bürkle E, Ebner FH, et al.  Estimation of Severity of Moyamoya Disease with [15O] Water-Positron Emission Tomography Compared with Magnetic Resonance Imaging and Angiography[J]. World Neurosurg, 2018, (117): e75-e81.DOI: 10.1016/j.wneu.2018.05.163..
[13] Acker G, Lange C, Schatka I, et al.  Brain Perfusion Imaging Under Acetazolamide Challenge for Detection of Impaired Cerebrovascular Reserve Capacity: Positive Findings with 15O-Water PET in Patients with Negative 99mTc-HMPAO SPECT[J]. J Nucl Med, 2018, 59(2): 294-298.   doi: 10.2967/jnumed.117.195818
[14] Kuhn FP, Warnock G, Schweingruber T, et al.  Quantitative H2[15O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization[J]. J Stroke Cerebrovasc Dis, 2015, 24(5): 965-971.   doi: 10.1016/j.jstrokecerebrovasdis.2014.12.017
[15] Eo JS, Jeong JM.  Angiogenesis Imaging Using 68Ga-RGD PET/CT: Therapeutic Implications[J]. Semin Nucl Med, 2016, 46(5): 419-427.   doi: 10.1053/j.semnuclmed.2016.04.001
[16] Choi H, Phi JH, Paeng JC, et al.  Imaging of Integrin αVβ3 Expression Using 68Ga-RGD Positron Emission Tomography in Pediatric Cerebral Infarct[J]. Mol Imaging, 2013, 12(4): 213-217.   doi: 10.2310/7290.2012.00036
[17] Kim YI, Phi JH, Paeng JC, et al.  In vivo evaluation of angiogenic activity and its correlation with efficacy of indirect revascularization surgery in pediatric moyamoya disease[J]. J Nucl Med, 2014, 55(9): 1467-1472.   doi: 10.2967/jnumed.114.142430
[18] Nakagawara J, Osato T, Kamiyama K, et al.  Diagnostic imaging of higher brain dysfunction in patients with adult moyamoya disease using statistical imaging analysis for [123I]iomazenil single photon emission computed tomography[J]. Neurol Med Chir (Tokyo), 2012, 52(5): 318-326.   doi: 10.2176/nmc.52.318
[19] Han JH, Park YS, Lee WH, et al.  Cerebral-perfusion-based single-photon emission computed tomography (SPECT) staging using NeuroGam® in patients with moyamoya disease[J]. Childs Nerv Syst, 2016, 32(8): 1471-1477.   doi: 10.1007/s00381-015-2974-1
[20] Ashburner J.  A fast diffeomorphic image registration algorithm[J]. Neuroimage, 2007, 38(1): 95-113.   doi: 10.1016/j.neuroimage.2007.07.007